Australia markets closed

CannPal Animal Therapeutics Limited (CP1.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.1850+0.0100 (+5.71%)
At close: 3:56PM AEDT
Currency in AUD

Valuation measures

Market cap (intra-day) 517.23M
Enterprise value 315.31M
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)24.46
Price/book (mrq)10.88
Enterprise value/revenue 321.74
Enterprise value/EBITDA 6N/A

Trading information

Stock price history

Beta (5Y monthly) 1.06
52-week change 315.62%
S&P500 52-week change 318.43%
52-week high 30.2450
52-week low 30.0690
50-day moving average 30.1798
200-day moving average 30.1338

Share statistics

Avg vol (3-month) 3391.24k
Avg vol (10-day) 3115.79k
Shares outstanding 593.12M
Float 55.44M
% held by insiders 142.12%
% held by institutions 119.88%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Jun 2020
Most-recent quarter (mrq)30 Jun 2020

Profitability

Profit margin -241.84%
Operating margin (ttm)-250.48%

Management effectiveness

Return on assets (ttm)-41.58%
Return on equity (ttm)-70.60%

Income statement

Revenue (ttm)704.42k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)-1.07M
EBITDA N/A
Net income avi to common (ttm)-1.7M
Diluted EPS (ttm)-0.0180
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.92M
Total cash per share (mrq)0.02
Total debt (mrq)N/A
Total debt/equity (mrq)N/A
Current ratio (mrq)5.82
Book value per share (mrq)0.02

Cash flow statement

Operating cash flow (ttm)-1.39M
Levered free cash flow (ttm)-788.4k